An extra 229,000 deaths: Is that the cost of US-UK drugs deal?
- Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain’s National Health Service (NHS).
- In December, the UK and US signed a pharmaceutical trade deal, under which the US government agreed not to impose tariffs on UK pharmaceutical and medical technology exports for the next three years.
- Recommended Stories list of 3 itemslist 1 of 3UK bill bans anyone born after 2008 from ever buying tobaccolist 2 of 3UK bans a generation of chi
Unverified
- Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain’s National Health Service (NHS).
- In December, the UK and US signed a pharmaceutical trade deal, under which the US government agreed not to impose tariffs on UK pharmaceutical and medical technology exports for the next three years.
- Recommended Stories list of 3 itemslist 1 of 3UK bill bans anyone born after 2008 from ever buying tobaccolist 2 of 3UK bans a generation of chi
Sources: Al Jazeera